Deloitte’s CFO Program is delighted to invite you to our “Japan Pharma: SG&A trends and the impact of Covid-19 on Commercial activities” webinar on September 11th. We will be hosting the webinar for Japanese Pharma CFOs / CPOs interested in hearing Deloitte’s Point of View on how SG&A trends and Covid-19 is impacting the industry and market.